Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR (Q73558673)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

A Uchida

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Nakata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Hatta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Kiyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Kawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Morimoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Miki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Moriguchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Nakamura

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Fujita

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Itoh

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Sasaki

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

K Takeda

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Nakagawa

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

455-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

Serum-insulin in essential hypertension and in peripheral vascular disease

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Insulin resistance in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension. Parallels between human disease and rodent models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Abnormalities of carbohydrate and lipid metabolism in Dahl rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

The Zucker fatty rat as a genetic model of obesity and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Abnormalities of insulin and lipid metabolism in Milan hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Effects of pioglitazone on calcium channels in vascular smooth muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Evidence that pioglitazone increases intracellular free magnesium concentration in freshly isolated rat adipocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Chronic sucrose ingestion induces mild hypertension and tachycardia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Effect of oral sucrose on blood pressure in the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Mechanism of insulin resistance in fructose-fed rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Fructose-induced insulin resistance and hypertension in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

High sucrose diets increase blood pressure of both salt-sensitive and salt-resistant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Vanadyl sulfate lowers plasma insulin and blood pressure in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Somatostatin inhibition of fructose-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Evidence against a role of insulin in hypertension in spontaneously hypertensive rats. CS-045 does not lower blood pressure despite improvement of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Attenuation of fructose-induced hypertension in rats by exercise training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Insulin insensitivity in nonobese, nondiabetic essential hypertension and its improvement by an alpha 1-blocker (bunazosin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Assessment of insulin sensitivity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Exaggerated pressor and chronotropic response to chronic hyperinsulinemia in SH versus WKY rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Effect of acute and chronic captopril infusion on blood pressure in the two-kidney, one clip hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900403-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(97)00403-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9244372%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference